Total Quality
Score
If You Had Traded on This Analysis…
Correct
UNH
Long Entry
271.5000
2025-08-15
03:30 UTC
Target
357.4000
In 4 Weeks
Fail
234.6000
Risk/Reward
1 : 2
Turn Signals into Profit
Join Tahlil Plus Pro to unlock full performance history, live alerts, and AI-backed risk tools.
Start Free
Final PnL
31.64%
P/L: —
Turn Signals into Profit
Join Tahlil Plus Pro to unlock full performance history, live alerts, and AI-backed risk tools.
Start Free
This analysis focuses on UNH, analyzing Warren Buffett's recent purchase of over 5 million shares, valued at $1.57 billion. The analysis notes the stock's 54% drop since April, attributing it to declining earnings and an investigation into their Medicare Advantage business. The stock is noted to be down 39% from its 200-day price average, with a PE ratio of 11 and a dividend yield of 3.26%. The analysis projects a decline in earnings per share for 2025 by 40%, resulting in a forward PE ratio of 16.5, but anticipates double-digit earnings growth in subsequent years, the analyst has set a target price of 357.40, which would imply a potential rebound from oversold status. Given the current price of 271.49 and the target price of 357.40, a fail bound is calculated at 234.60 USD which is bellow the current price, if the price drops to that point will invalidate the overall analysis.
